Skip to main content
Year archive

BioPorto — 2018 filings

All 28 regulatory filings released by BioPorto (BIOPOR) in 2018, sourced directly from the official regulator.

28 Filings
2018 Period
2018 filings (28)
Filing Released Lang
Share Capital and Votes
Share Issue/Capital Change
2018-11-28 English
Share Capital and Votes
Share Issue/Capital Change
2018-11-28 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-20 English
Announcement from major shareholder
Major Shareholding Notification
2018-11-20 English
BioPorto A/S increases the share capital through a cash issue, private placement
Share Issue/Capital Change
2018-11-12 English
Share Issue/Capital Change 2018
Share Issue/Capital Change
2018-11-12 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-08 English
Regulatory Filings 2018
Regulatory Filings
2018-10-03 English
BioPorto receives communication from FDA regarding The NGAL Test™
Regulatory Filings
2018-10-03 English
Regulatory Filings 2018
Regulatory Filings
2018-10-02 English
BioPorto initiates pivotal clinical study with The NGAL Test™ for children  
Regulatory Filings
2018-10-02 English
Interim Report, Second Quarter 2018, BioPorto Group
Interim / Quarterly Report H1 2018
2018-08-16 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-16 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-16 English
Interim Report, Second Quarter 2018, BioPorto Group
Interim / Quarterly Report H1 2018
2018-08-16 English
Regulatory Filings 2018
Regulatory Filings
2018-07-18 English
BioPorto submits FDA application for The NGAL Test™
Regulatory Filings
2018-07-18 English
Regulatory Filings 2018
Regulatory Filings
2018-06-27 English
BioPorto has finalized clinical studies enabling submission of the FDA application for The NGAL Test™ in July 2018
Regulatory Filings
2018-06-27 English
Regulatory Filings 2018
Regulatory Filings
2018-04-03 English
BioPorto receives intention to grant for a divisional NGAL cutoff patent in Europe
Investor Presentation
2018-04-03 English
Report Publication Announcement 2017
Report Publication Announcement FY 2017
2018-03-08 English
Annual Report 2017
Annual Report FY 2017
2018-03-08 English
Execution, Growth and Increased Awareness
Audit Report / Information FY 2017
2018-03-08 Danish
Regulatory Filings 2018
Regulatory Filings
2018-03-06 English
BioPorto finalizes enrolment of patients for The NGAL Test™ clinical study in the US and plans submission of FDA application in Q2 2018.
Regulatory Filings
2018-03-06 English
Regulatory Filings 2018
Regulatory Filings
2018-02-09 English
BioPorto and Roche Diagnostics sign a distribution agreement for NGAL
Regulatory Filings
2018-02-09 English